Robert Ohgami

Pathologist, Hematopathologist, Surgical pathologist

Clinical Instructor, Pathology

Professional Education

Board Certification: Hematology, American Board of Pathology

Residency: Stanford Hospital and Clinics (2012) CA

Fellowship: Stanford Hospital and Clinics (2011) CA

BA, Princeton, Molecular Biology (2000)

Medical Education: Harvard Medical School (2008) MA

Medical Education (HST), Massachusetts Institute of Technology, MA (2008)

PhD, Harvard, Cell and Developmental Biology (2006)

Board Certification, American Board of Pathology, Hematology (2012)

Board Certification, American Board of Pathology, Anatomic Pathology (2012)

Honors & Awards

Research Scholar, College of American Pathologists (2012)

Administrative Appointments

Associate Director, Stanford Society of Physician Scholars, 2010

Member, College of American Pathologists (CAP) Cancer Biomarker Reporting Committee (CBRC) Hematopathology, 2013

Associate Member, Stanford Cancer Institute, 2013

E-Cadherin Is a Specific Marker for Erythroid Differentiation and Has Utility, in Combination With CD117 and CD34, for Enumerating Myeloblasts in Hematopoietic Neoplasms.
Ohgami, R. S., Chisholm, K. M., Ma, L., & Arber, D. A. (2014). E-Cadherin Is a Specific Marker for Erythroid Differentiation and Has Utility, in Combination With CD117 and CD34, for Enumerating Myeloblasts in Hematopoietic Neoplasms. American journal of clinical pathology, 141(5), 656-664.

Indolent T-lymphoblastic Proliferation With Disseminated Multinodal Involvement and Partial CD33 Expression.
Ohgami, R. S., Sendamarai, A. K., Atwater, S. K., Liedtke, M., Fleming, M. D., & Warnke, R. A. (2014). Indolent T-lymphoblastic Proliferation With Disseminated Multinodal Involvement and Partial CD33 Expression. The American journal of surgical pathology.

Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas.
Ohgami, R. S., Zhao, S., & Natkunam, Y. (2014). Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas. American journal of clinical pathology, 142(2), 150-6.

STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.
Ohgami, R. S., Ma, L., Monabati, A., Zehnder, J. L., & Arber, D. A. (2014). STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression. Haematologica.

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
Ohgami, R. S., Ma, L., Merker, J. D., Martinez, B., Zehnder, J. L., & Arber, D. A. (2013). STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Leukemia, 27(11), 2244-2247.

TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma
Ohgami, R. S., Zhao, S., Ohgami, J. K., Leavitt, M. O., Zehnder, J. L., & Warnke, R. A. (2012). TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(11), 1619-1628.

DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups
Ohgami, R. S., Ma, L., Ren, L., Weinberg, O. K., Seetharam, M., & Arber, D. A. (2012). DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups. BRITISH JOURNAL OF HAEMATOLOGY, 159(2), 182-190.

Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies
Ohgami, R. S., Ohgami, J. K., Pereira, I. T., Gitana, G., Zehnder, J. L., & Arber, D. A. (2011). Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies. LEUKEMIA, 25(9), 1439-1443.

Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings.
Weinberg, O. K., Ohgami, R. S., Ma, L., Seo, K., Ren, L., & Arber, D. A. (2014). Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings. American journal of clinical pathology, 142(2), 190-195.

Profound plasmacytosis in a patient with dengue.
Ewalt, M. D., Abeynayake, J., Waggoner, J. J., Pinsky, B. A., & Ohgami, R. S. (2013). Profound plasmacytosis in a patient with dengue. International journal of hematology, 98(5), 518-519.

Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami, R. S., Arber, D. A., Zehnder, J. L., Natkunam, Y., & Warnke, R. A. (2013). Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Advances in anatomic pathology, 20(3), 137-140.

Challenges in Consolidated Reporting of Hematopoietic Neoplasms
Ohgami, R. S., & Arber, D. A. (2013). Challenges in Consolidated Reporting of Hematopoietic Neoplasms. Surgical Pathology Clinics.

The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow
Younes, S. F., Beck, A. H., Ohgami, R. S., Lossos, I. S., Levy, R., & Natkunam, Y. (2011). The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 135(5), 697-708.

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma
Sangoi, A. R., Ohgami, R. S., Pai, R. K., Beck, A. H., McKenney, J. K., & Pai, R. K. (2011). PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma. MODERN PATHOLOGY, 24(3), 412-424.

Diagnosing PNH in the era of FLAER
K, H., R, O. S., D, A. A., A, A., & St, C. (2011). Diagnosing PNH in the era of FLAER. Blood, [e-letter].

Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle
Sendamarai, A. K., Ohgami, R. S., Fleming, M. D., & Lawrence, C. M. (2008). Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(21), 7410-7415.

The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006). The Steap proteins are metalloreductases. BLOOD, 108(4), 1388-1394.

nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse
Ohgami, R. S., Campagna, D. R., Antiochos, B., Wood, E. B., Sharp, J. J., & Fleming, M. D. (2005). nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. BLOOD, 106(10), 3625-3631.

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells
Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., & Fleming, M. D. (2005). Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. NATURE GENETICS, 37(11), 1264-1269.